Acción 000597 NORTHEAST PHARMACEUTICAL GROUP CO., LTD.
Añadir a una lista
Para utilizar esta función debe ser un cliente o miembro.
ConéctateRegístrate

Otros idiomas Northeast Pharmaceutical Group Co., Ltd.

Acciones

000597

CNE0000009G0

Precio de cierre Shenzhen S.E.
Otros sitios de cotización
 00:00:00 30/04/2024 		Varia. Cinco días. Varia. 1 de enero.
4,75 CNY +1,93 % Gráfico intradía de Northeast Pharmaceutical Group Co., Ltd. +1,50 % -11,21 %
25/04 Northeast Pharmaceutical Group Co. informa de los resultados del primer trimestre finalizado el 31 de marzo de 2024 CI
29/03 Northeast Pharmaceutical Group Co. informa de los resultados del ejercicio cerrado el 31 de diciembre de 2023 CI

Otros idiomas

Buscar
Ver los resultados
Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!
Inscripción 100% Gratuita
Northeast Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
Northeast Pharmaceutical Group Co., Ltd. Proposes Profit Distribution for 2023
Northeast Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
Northeast Pharmaceutical's Levocarnitine Gets Nod to Enter EU Market
Northeast Pharmaceutical's Piracetam Passes Generic Drug Evaluation in China
Northeast Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
Northeast Pharmaceutical to Set Up Joint Venture With Muscat Changming Investments in Oman
Northeast Pharmaceutical Group Co., Ltd.(XSEC:000597) added to S&P Global BMI Index
Northeast Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
Northeast Pharmaceutical Group Co., Ltd. Announces 2022 Final Cash Profit Distribution Plan, Payable on 16 May 2023
Northeast Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
Northeast Pharmaceutical Group Co., Ltd. Approves Final Cash Dividend for 2022
Northeast Pharmaceutical Group Co., Ltd. Proposes Final Cash Dividend for 2022
Northeast Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
China Monthly Antitrust Update - March 2023
Northeast Pharma Appoints Former Bank Auditor as CFO
Northeast Pharmaceutical Unit Registers Anti-Seizure Drug in China
Northeast Pharmaceutical’s Piracetam Tablets Gets Regulatory Approval
Northeast Pharmaceutical Gets Supplementary Drug Application Approval For Tinidazole Tablets
Northeast Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
No hay resultados para esta búsqueda
Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Buscar

Fecha de publicación

De

Hasta

  1. Bolsa de valores
  2. Acciones
  3. Acción 000597
  4. Noticias Northeast Pharmaceutical Group Co., Ltd.
  5. Otros idiomas